Skip to main content
  • Home
  •  ACC 2019: Duration Of Diabetes And Cardiorenal Efficacy Of Liraglutide And Semaglutide - Prof Subodh Verma

ACC 2019: Duration Of Diabetes And Cardiorenal Efficacy Of Liraglutide And Semaglutide - Prof Subodh Verma

Topic:
  • Prevention

Available Credit:

  • Not accredited

Course Published On:

Course Expiry Date:

Overview

Prof Subodh Verma (University of Toronto, Toronto, CA) discusses his poster presented at the ACC 2019 entitled duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - a post hoc analysis of the LEADER and SUSTAIN-6 Clinical Trials.

Target Audience

  • Cardiologists 
  • Diabetologists
  • Nephrologists 
This course is not accredited

Related Courses

Advancements in Triglyceride-lowering Therapies
  • 1.00 EBAC

Learning objectives

  • Recall the primary and secondary outcomes from key triglyceride-lowering trials presented during ESC 2024
  • Discuss the current and future implication of trial results to clinical management and practice guidelines
See more
Elevating Understanding and Management of Hypertriglyceridemia
  • 1.25 AMA PRA Credit

Learning objectives

  • Understand HTG as a risk factor for acute and chronic illness
  • Describe current guideline directed management of HTG
  • Recognise the gaps and challenges present in current guideline directed management of HTG
  • Recall emerging trial data for novel pharmacological targets
  • Use guidelines, trial data & expert opinion to develop individualised treatment strategies for high-risk patients
See more